MELVILLE, N.Y.--(BUSINESS WIRE)--Bovie Medical Corporation (the “Company”) (Amex: BVX - News), a manufacturer and marketer of electrosurgical products, today announced that the Food & Drug Administration has cleared its Modular Ergonomic Instruments (MEG Laparoscopic line), allowing the MEG line to be marketed and sold throughout the United States. The patent-pending modular forceps and accessories are designed to provide surgeons added comfort while reducing per-procedure costs through the reduction of inventory and obsolescence. The proprietary instruments offer a simpler assembly process for laparoscopic procedures. The MEG line is directed towards the laparoscopic market with estimated worldwide sales exceeding $425 million.
In other news, the Company recently filed a 510(k) application with the FDA for its ICON GP generator. The ICON GP will be used as a stand-alone advanced general purpose generator as well as in conjunction with the Company’s Polarian vessel sealing instruments currently under development.
This document may contain some forward looking statements, particularly regarding operational prospects in 2008 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company’s SEC filings. www.boviemedical.com
Contact:
Investor Relations: Buttonwood Advisory Group, Inc. John Aneralla, 800-940-9087
Source: Bovie Medical Corporation
